Bhat Laxminarayan 13D and 13G filings for Reviva Pharmaceuticals Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-20 4:30 pm Purchase |
2024-12-18 | 13D | Reviva Pharmaceuticals Holdings, Inc. RVPH |
Bhat Laxminarayan | 3,198,242 6.800% |
304,328 (+10.52%) |
Filing |
| 2024-08-23 4:06 pm Purchase |
2024-08-22 | 13D | Reviva Pharmaceuticals Holdings, Inc. RVPH |
Bhat Laxminarayan | 2,893,914 8.600% |
8,236 (+0.29%) |
Filing |
| 2024-02-16 4:32 pm Purchase |
2023-11-20 | 13D | Reviva Pharmaceuticals Holdings, Inc. RVPH |
Bhat Laxminarayan | 2,885,678 10.200% |
74,133 (+2.64%) |
Filing |
| 2023-05-05 4:30 pm Purchase |
2023-04-25 | 13D | Reviva Pharmaceuticals Holdings, Inc. RVPH |
Bhat Laxminarayan | 2,811,545 13.500% |
332,689 (+13.42%) |
Filing |
| 2020-12-21 4:02 pm Purchase |
2020-12-14 | 13D | Reviva Pharmaceuticals Holdings, Inc. RVPH |
Bhat Laxminarayan | 2,478,856 26.900% |
2,478,856 (New Position) |
Filing |